Osimertinib
- All
- News
-
Research And Development In Lung Cancer
- Wednesday February 5, 2025
- Dr (Prof) Kumar Prabash, Dr (Prof) Vanita Noronha and Dr Kunal Jobanputra
This article is a part of Lung Connect India Foundation's initiative 'Lung Cancer Awareness - United In Our Goals', focusing on lung cancer prevention, diagnosis, and treatment.
-
doctor.ndtv.com
-
Budget 2024: Centre To Remove Customs Duty On 3 Life-Saving Cancer Medicines
- Tuesday July 23, 2024
- Business News | NDTV News Desk
Union Finance Minister Nirmala Sitharaman proposed to completely slash the custom duties on three cancer medicines. Centre has proposed to cut the custom duties on Trastuzumab Deruxtecan, Osimertinib and Durvalumab from 10 per cent to zero.
-
www.ndtv.com
-
Lung Cancer Pill Significantly Lowers The Risk Of Death After Surgery: Study
- Tuesday June 6, 2023
- Feature | Edited by Nikhil Pandey
Impressive outcomes from a lung cancer drug have been reported in recently published research over the weekend.
-
www.ndtv.com
-
Research And Development In Lung Cancer
- Wednesday February 5, 2025
- Dr (Prof) Kumar Prabash, Dr (Prof) Vanita Noronha and Dr Kunal Jobanputra
This article is a part of Lung Connect India Foundation's initiative 'Lung Cancer Awareness - United In Our Goals', focusing on lung cancer prevention, diagnosis, and treatment.
-
doctor.ndtv.com
-
Budget 2024: Centre To Remove Customs Duty On 3 Life-Saving Cancer Medicines
- Tuesday July 23, 2024
- Business News | NDTV News Desk
Union Finance Minister Nirmala Sitharaman proposed to completely slash the custom duties on three cancer medicines. Centre has proposed to cut the custom duties on Trastuzumab Deruxtecan, Osimertinib and Durvalumab from 10 per cent to zero.
-
www.ndtv.com
-
Lung Cancer Pill Significantly Lowers The Risk Of Death After Surgery: Study
- Tuesday June 6, 2023
- Feature | Edited by Nikhil Pandey
Impressive outcomes from a lung cancer drug have been reported in recently published research over the weekend.
-
www.ndtv.com